東陽光藥(01558.HK):利伐沙班片已獲中國審批上市 2021-05-25T10:49:20-04:00May 25th, 2021| share this article!【財華社訊】東陽光藥(01558.HK)公佈,該公司自廣東東陽光藥業收購之產品利伐沙班片(10mg、15mg及20mg)已獲中國國家藥品監督管理局審批完畢並獲准上市。 Read More share this article! Related Posts Chinese carmaker Chery banks on battery technology to rev up transition to EVs May 18th, 2024 Dow ends above 40,000 milestone, other indexes notch weekly gains May 17th, 2024 India: Wipro COO Amit Choudhary quits, business head Jain to take over May 17th, 2024 Haidilao restaurant operator Super Hi surges 46% on U.S. listing debut May 17th, 2024